Pfizer Recalls Inderal-la (propranolol Hydrochloride) Capsules Due To A Nitrosamine Impurity
Pfizer is recalling Inderal-LA propranolol hydrochloride capsules in 60 mg, 80 mg, 120 mg, and 160 mg strengths across Canada because they contain a nitrosamine impurity. Nitrosamines are contaminants that may pose a health risk with long-term exposure. The recall affects all Canadian patients who have been prescribed this medication.
- Product
- Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths
- Reason
- Contamination
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2022-03-01
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/db5459eb-7cc9-4e13-9f2d-8f65cac1b02d